Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CME for off-label device uses is not shielded by First Amendment -- Public Citizen..

This article was originally published in The Gray Sheet

Executive Summary

INDUSTRY-SPONSORED TRAINING IN OFF-LABEL DEVICE, DRUG USES constitutes "misleading" promotional activity and is "therefore not entitled to first amendment protection," Public Citizen argues in Feb. 16 comments to FDA. The comments respond to a Washington Legal Foundation petition challenging FDA's authority to regulate discussion of unapproved device or drug uses at industry-sponsored continuing medical education forums.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003506

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel